DSM-Firmenich AG
AEX:DSFIR

Watchlist Manager

DSM-Firmenich AG

AEX:DSFIR

Watchlist

Discount Rate

Price: 116.45 EUR 0.39% Market Closed

Market Cap: 31B EUR

Have any thoughts about
DSM-Firmenich AG?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	Abbvie Inc NYSE:ABBV	Biotechnology
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Realty Income Corp NYSE:O	Real Estate
US	Walt Disney Co NYSE:DIS	Media
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 116.45 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

DSFIR Alert

DSM-Firmenich AG

116.45

+0.45 (+0.39%)

52 Week Range	76.13 123.2
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	Abbvie Inc NYSE:ABBV	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Realty Income Corp NYSE:O	US
	Walt Disney Co NYSE:DIS	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

DSM-Firmenich AG

What unique competitive advantages
does DSM-Firmenich AG hold over its rivals?

What risks and challenges
does DSM-Firmenich AG face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of DSM-Firmenich AG.

What unique competitive advantages
does DSM-Firmenich AG hold over its rivals?

What risks and challenges
does DSM-Firmenich AG face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for DSM-Firmenich AG.

Provide P/S
for DSM-Firmenich AG.

Provide P/E
for DSM-Firmenich AG.

Provide P/OCF
for DSM-Firmenich AG.

Provide P/FCFE
for DSM-Firmenich AG.

Provide P/B
for DSM-Firmenich AG.

Provide EV/S
for DSM-Firmenich AG.

Provide EV/GP
for DSM-Firmenich AG.

Provide EV/EBITDA
for DSM-Firmenich AG.

Provide EV/EBIT
for DSM-Firmenich AG.

Provide EV/OCF
for DSM-Firmenich AG.

Provide EV/FCFF
for DSM-Firmenich AG.

Provide EV/IC
for DSM-Firmenich AG.

Show me price targets
for DSM-Firmenich AG made by professional analysts.

What are the Revenue projections
for DSM-Firmenich AG?

How accurate were the past Revenue estimates
for DSM-Firmenich AG?

What are the Net Income projections
for DSM-Firmenich AG?

How accurate were the past Net Income estimates
for DSM-Firmenich AG?

What are the EPS projections
for DSM-Firmenich AG?

How accurate were the past EPS estimates
for DSM-Firmenich AG?

What are the EBIT projections
for DSM-Firmenich AG?

How accurate were the past EBIT estimates
for DSM-Firmenich AG?

Compare the revenue forecasts
for DSM-Firmenich AG with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of DSM-Firmenich AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of DSM-Firmenich AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of DSM-Firmenich AG compared to its peers.

Compare the P/E ratios
of DSM-Firmenich AG against its peers.

Discuss the investment returns and shareholder value creation
comparing DSM-Firmenich AG with its peers.

Analyze the financial leverage
of DSM-Firmenich AG compared to its main competitors.

Show all profitability ratios
for DSM-Firmenich AG.

Provide ROE
for DSM-Firmenich AG.

Provide ROA
for DSM-Firmenich AG.

Provide ROIC
for DSM-Firmenich AG.

Provide ROCE
for DSM-Firmenich AG.

Provide Gross Margin
for DSM-Firmenich AG.

Provide Operating Margin
for DSM-Firmenich AG.

Provide Net Margin
for DSM-Firmenich AG.

Provide FCF Margin
for DSM-Firmenich AG.

Show all solvency ratios
for DSM-Firmenich AG.

Provide D/E Ratio
for DSM-Firmenich AG.

Provide D/A Ratio
for DSM-Firmenich AG.

Provide Interest Coverage Ratio
for DSM-Firmenich AG.

Provide Altman Z-Score Ratio
for DSM-Firmenich AG.

Provide Quick Ratio
for DSM-Firmenich AG.

Provide Current Ratio
for DSM-Firmenich AG.

Provide Cash Ratio
for DSM-Firmenich AG.

What is the historical Revenue growth
over the last 5 years for DSM-Firmenich AG?

What is the historical Net Income growth
over the last 5 years for DSM-Firmenich AG?

What is the current Free Cash Flow
of DSM-Firmenich AG?

Discuss the annual earnings per share (EPS)
trend over the past five years for DSM-Firmenich AG.

Financials Section:

Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

35.1B

+102%

Assets

Jun 30, 2023	35.1B
Dec 31, 2022	17.4B
Jun 30, 2022	36.7B

12.1B

+82%

Liabilities

Jun 30, 2023	12.1B
Dec 31, 2022	6.7B
Jun 30, 2022	12.1B

23B

+114%

Equity

Jun 30, 2023	23B
Dec 31, 2022	10.7B
Jun 30, 2022	24.6B

Balance Sheet Decomposition
DSM-Firmenich AG

Current Assets	10.3B
Cash & Short-Term Investments	3.4B
Receivables	3.1B
Other Current Assets	3.9B
Non-Current Assets	24.8B
Long-Term Investments	965m
PP&E	5.3B
Intangibles	18.4B
Other Non-Current Assets	135m

Current Liabilities	4.8B
Accounts Payable	2.1B
Other Current Liabilities	2.7B
Non-Current Liabilities	7.3B
Long-Term Debt	4.1B
Other Non-Current Liabilities	3.2B

Balance Sheet
DSM-Firmenich AG

Rotate your device to view
Balance Sheet

Currency: EUR

	Dec-2022	Dec-2023
Assets
Cash & Cash Equivalents	2 755	2 456
Cash	0	1 141
Cash Equivalents	2 755	1 315
Short-Term Investments	125	107
Total Receivables	1 622	2 843
Accounts Receivables	1 508	2 553
Other Receivables	114	290
Inventory	2 339	3 390
Other Current Assets	1 287	48
Total Current Assets	8 128	8 844
PP&E Net	3 576	5 549
PP&E Gross	0	5 549
Accumulated Depreciation	0	4 422
Intangible Assets	5 147	7 445
Goodwill	0	11 293
Note Receivable	0	100
Long-Term Investments	375	721
Other Long-Term Assets	177	318
Other Assets	0	11 293
Total Assets	17 403 N/A	34 270 +97%
Liabilities
Accounts Payable	1 415	2 071
Accrued Liabilities	0	220
Short-Term Debt	0	0
Current Portion of Long-Term Debt	86	716
Other Current Liabilities	1 079	1 512
Total Current Liabilities	2 580	4 519
Long-Term Debt	2 978	4 114
Deferred Income Tax	476	1 751
Minority Interest	102	162
Other Liabilities	524	816
Total Liabilities	6 660 N/A	11 362 +71%
Equity
Common Stock	0	3
Retained Earnings	0	10 744
Additional Paid In Capital	0	11 731
Treasury Stock	0	44
Other Equity	10 743	474
Total Equity	10 743 N/A	22 908 +113%
Total Liabilities & Equity	17 403 N/A	34 270 +97%
Shares Outstanding
Common Shares Outstanding	151	265

Switch to:

Income Statement Balance Sheet Cash Flow Statement

Switch to:

Income Statement Balance Sheet Cash Flow Statement

DSM-Firmenich AG
AEX:DSFIR

Balance Sheet

Balance Sheet Decomposition
DSM-Firmenich AG

Balance Sheet
DSM-Firmenich AG

See Also

Company

Help

Tools

Stocks

DSM-Firmenich AG AEX:DSFIR

Balance Sheet

Balance Sheet Decomposition DSM-Firmenich AG

Balance Sheet DSM-Firmenich AG

See Also

Company

Help

Tools

Stocks

DSM-Firmenich AG
AEX:DSFIR

Balance Sheet Decomposition
DSM-Firmenich AG

Balance Sheet
DSM-Firmenich AG